News Daily News Nephroprotective NOACs? Renal Dysfunction Not Infrequent Among A-fib Patients, but Some Agents Reduce Risk Yael L. Maxwell November 28, 2017
News Daily News DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis Michael O'Riordan October 19, 2017
News Daily News Blood in Urine Carries Consequences for Patients on Antithrombotics Yael L. Maxwell October 09, 2017
News Daily News Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early Todd Neale October 09, 2017
News Daily News NOAC Bleeding Risk Rises With Several Drug Combinations Michael O'Riordan October 06, 2017
News Daily News Rivaroxaban, Warfarin Provide Similar Results Early After Mild Strokes Related to A-fib Todd Neale September 14, 2017
News Daily News Extended Low-Dose Ticagrelor May Prevent Adverse Events Post-MI, Study Finds Yael L. Maxwell September 12, 2017
News Daily News In Case of Emergency: Don’t Rely on ‘Normal’ Range Assays With DOACs Shelley Wood August 10, 2017
News Daily News Aspirin Use by Elderly Patients After Vascular Events Linked to More Bleeding, Especially GI Bleeds Michael O'Riordan June 14, 2017
News Daily News Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women Todd Neale May 11, 2017
News Daily News Drugs Most Heavily Promoted by Pharma Don’t Necessarily Offer the Best Health Value Todd Neale May 04, 2017
News Daily News Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats L.A. McKeown May 03, 2017
News Daily News If You Don’t Take Your Stroke Meds, This App Will Tell on You Todd Neale April 18, 2017
News Daily News Do NOACs Carry a Higher Risk of Acute MI? New Study Reopens Old Questions Todd Neale March 28, 2017
News Daily News NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease Todd Neale March 14, 2017
News Daily News Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS Todd Neale February 08, 2017
News Daily News Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban Michael O'Riordan January 03, 2017